A Better Alternative To Dried Blood Spot

Volumetric Absorptive Microsampling (VAMS™), the technology behind Mitra^® devices, retains the benefits of DBS cards while solving for their limitations.

Download these case studies from Exagen Diagnostics, GlaxoSmithKline, and others to see the following benefits vs DBS cards:

Superior analytical performance with better correlation to plasma
More simple, user-friendly dried blood collection approach

Compatibility with 96-well formats for fast sample extractions

Collect a homogeneous sample every time resulting in fewer rejects

When Dried Blood Spot (DBS) cards debuted more than 50 years ago, they had significant advantages over traditional wet sampling, including simplicity, low cost, and ease of transportation.

But adoption has been hindered by regulatory concerns over the "Hematocrit (HCT) Effect," along with their automation limitations. In addition, incorrect spotting technique can lead to high sample rejection rates.

The FDA Class 1 Mitra^® Microsampler is a novel specimen collection device that retains the advantages of Dried Blood Spot cards and solves for their limitations.

dried blood spot versus mitra vams microsampler

With traditional Dried Blood Spot cards, sample volume can vary considerably. With the Mitra microsampler, you will gather a precise and accurate volume, easily, the first time.

Mitra provides an simlpler faster workflow compared to dried blood spot cards

Dried blood Spot cards take time to dry. With Mitra microsampler, there's no need to wait - simply sample and ship.

Mitra Cartridges come standard with native bar coding, allowing for quick processing

Tracking Dried Blood Spot cards requires manual data entry, which creates extra work and errors. With microsampling, you can track your samples with native barcodes.

The Mitra system offers a 96 Autorack which is compatible with liquid handlers, allowing you to by-pass DBS punching

Microsampling saves time by cutting superfluous steps. No more punching.

Autoracks are compatible with solvent collection plates

Stop hassling with punched paper – Mitra Microsamples have been designed for compatibility with solvent collection plates.

The Mitra Microsampler class I medical device is for direct specimen collection and transportation of blood and other biological fluids. It is not specific to any clinical test, and is not for use in diagnostic procedures. Use of the Mitra Microsampler in Laboratory Developed Tests (LDTs) requires further processing including the establishment of performance characteristics and successful validation by the laboratory in a manner consistent with CLIA requirements. The Mitra Microsampling Device is a FDA listed Class 1 exempt device. Neoteryx operates a Quality Management System (QMS) that is based on FDA good manufacturing practices, 21 CFR 820 regulations, and ISO-13485.

the next-generation dried blood spot

Time to stop using DBS cards. Here's why!

Mitra^® microsampling combines the best of traditional wet sampling and dried blood spotting in a state-of-the-art collection device.

Neoteryx, LLC

Drop us a line

the next-generation dried blood spot

Time to stop using DBS cards. Here's why!

Mitra® microsampling combines the best of traditional wet sampling and dried blood spotting in a state-of-the-art collection device.

Neoteryx, LLC

Drop us a line

Mitra^® microsampling combines the best of traditional wet sampling and dried blood spotting in a state-of-the-art collection device.